Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis.
Miyake Y, Yamamoto K, Matsushita H, Abe M, Takahashi A, Umemura T, Tanaka A, Nakamuta M, Nakamoto Y, Ueno Y, Saibara T, Takikawa H, Yoshizawa K, Ohira H, Zeniya M, Onji M, Tsubouchi H; Intractable Hepato-Biliary Disease Study Group of Japan.
Miyake Y, et al. Among authors: tanaka a.
Hepatol Res. 2014 Dec;44(13):1299-307. doi: 10.1111/hepr.12305. Epub 2014 Mar 6.
Hepatol Res. 2014.
PMID: 24506172